Australia's Cogstate hits over 2-year high on nearly doubling profit
** Shares of Cogstate CGS.AX rise as much as 8.1% to A$1.88, highest level since Feb. 20, 2023 ** The biotech company posts FY25 net profit after tax of A$13.9 million ($8.93 million), 96% higher than previous year ** About 145,190 shares change hands, almost double the 30-day avg of around 73,003 ** Shares last up 4.6%, adding to YTD gains of 74.2% ($1 = 1.5569 Australian dollars) (Reporting by Anjali Singh in Bengaluru) ((anjali.singh2@thomsonreuters.com;))
Recent news on Cogstate
See all newsAustralia's Cogstate gains most in nearly 2 months on revenue boost from contracts
Brief: Cogstate Posts 3Q26 Sales Contracts Executed Total $25.4 Million
Australia's Cogstate hits one-month high on upbeat half-yearly earnings
Brief: Cogstate Ltd Forecasts 1H26 Revenue At $25-$26 Million
Australia's Cogstate tumbles most in nearly 7 years on weak outlook